Reduce time to heal UrgoStartAlso available: UrgoStart Contact and UrgoStart Border menu description  

DOWNLOAD CLINICAL PAPERS ON PROTEASE INHIBITORS

 

Reality of a pooled data analysis

 

The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings.


A number of randomised controlled trials (RCT) have compared control groups with TLC-NOSF dressings (UrgoStart) on chronic wounds. Our aim was to determine whether the clinical trials’ results translate into routine management of such wounds, by pooling the data from real-life observational studies

 

 

Download the clinical paper



Reality of a pooled data analysis

 

Evidence in venous ulcer management a new consensus recommendation.


Wound healing usually follows a predictable sequence. However, in some individuals it can be prolonged, or may never be fully achieved. The non-healing or hard-to-heal wound has become an ongoing burden to the VLU patient, the practitioner and the health economy, resulting in poor health outcomes and decreased quality of life for the patient, coupled with an increased cost to the economy

  

Download the clinical paper




Evaluation of the NOSF matrix in venous leg ulcer

 

Evaluation of the nano-oligosaccharide factor lipidocolloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial.


The nano-oligosaccharide factor (NOSF) is a new compound aiming to promote wound closure mainly through inhibition of matrix metalloproteinase (MMP) activity.

 

Download the clinical paper




Using treatment pathways to improve healing of venous leg ulceration

 

Using treatment pathways to improve healing of venous leg ulceration.


To evaluate whether the implementation of evidence-based treatment pathways would lead to complete healing in 70% of people with venous leg ulceration at 24 weeks.

 

Download the clinical paper